B-cell prolymphocytic leukemia other diagnostic studies: Difference between revisions
Carlos Lopez (talk | contribs) No edit summary |
No edit summary |
||
| Line 5: | Line 5: | ||
==Overview== | ==Overview== | ||
Another diagnostic study for B-cell prolymphocytic leukemia includes [[immunophenotyping]]. | |||
==Immunophenotyping== | ==Immunophenotyping== | ||
[[Flow cytometry|Flow cytometric]] [[immunophenotyping]] indicates that the most common [[Malignant|malignant cells]] are positive for:<ref name="PLL">{{cite web | title = National Cancer Institute| url =http://seer.cancer.gov/seertools/hemelymph/51f6cf58e3e27c3994bd53f9/}}</ref> | |||
* CD20 | * [[CD20]] | ||
* CD22 | * [[CD22]] | ||
* CD23 | * [[CD23]] | ||
* CD79a | * [[CD79a]] | ||
* CD79b | * [[CD79b]] | ||
* FMC7 | * [[FMC7]] | ||
* Strong surface IgM +/- IgD | * Strong [[Immunoglobulin M|surface IgM]] +/- [[IgD]] | ||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
[[Category:Leukemia]] | [[Category:Leukemia]] | ||
Revision as of 19:07, 8 April 2019
|
B-cell prolymphocytic leukemia |
|
Differentiating B-cell prolymphocytic leukemia from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
B-cell prolymphocytic leukemia other diagnostic studies On the Web |
|
American Roentgen Ray Society Images of B-cell prolymphocytic leukemia other diagnostic studies |
|
FDA on B-cell prolymphocytic leukemia other diagnostic studies |
|
CDC on B-cell prolymphocytic leukemia other diagnostic studies |
|
B-cell prolymphocytic leukemia other diagnostic studies in the news |
|
Blogs on B-cell prolymphocytic leukemia other diagnostic studies |
|
Directions to Hospitals Treating B-cell prolymphocytic leukemia |
|
Risk calculators and risk factors for B-cell prolymphocytic leukemia other diagnostic studies |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Carlos A Lopez, M.D. [2]
Overview
Another diagnostic study for B-cell prolymphocytic leukemia includes immunophenotyping.
Immunophenotyping
Flow cytometric immunophenotyping indicates that the most common malignant cells are positive for:[1]